NCT06578650View on ClinicalTrials.gov

A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms

RecruitingOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2027

Conditions
Surgical Wound
Interventions
DEVICE

Synthetic Electrospun Fiber Matrix

Patients who are eligible for enrollment will be treated with Synthetic Electrospun Fiber Matrix immediately after surgical resection to the resulting wound

Trial Locations (1)

89102

RECRUITING

University Nevada - Las Vegas, Las Vegas

Sponsors
All Listed Sponsors
lead

Acera Surgical, Inc.

INDUSTRY

NCT06578650 - A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms | Biotech Hunter | Biotech Hunter